Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Lung Cancer

  Free Subscription


Articles published in J Immunol

Retrieve available abstracts of 8 articles:
HTML format



Single Articles


    March 2025
  1. SNYDER M, Wang Z, Lara B, Fimbres J, et al
    The aryl hydrocarbon receptor controls IFN-gamma-induced immune checkpoints PD-L1 and IDO via the JAK/STAT pathway in lung adenocarcinoma.
    J Immunol. 2025;214:413-432.
    PubMed     Abstract available


    November 2024
  2. MA B, Kamle S, Sadanaga T, Lee CM, et al
    Chitinase 3-like-1 Inhibits Innate Antitumor and Tissue Remodeling Immune Responses by Regulating CD47-SIRPalpha- and CD24-Siglec10-Mediated Phagocytosis.
    J Immunol. 2024;213:1279-1291.
    PubMed     Abstract available


    October 2024
  3. OZAKINCI H, Song X, Nazario GS, Lila T, et al
    Rapid Autopsy to Define Dendritic Cell Spatial Distribution and T Cell Association in Lung Adenocarcinoma.
    J Immunol. 2024;213:1033-1041.
    PubMed     Abstract available


    September 2024
  4. DIAMANTOPOULOS N, Li J, Bouchard A, Joumier L, et al
    ICOS-expressing Regulatory T Cells Influence the Composition of Antitumor CTL Populations.
    J Immunol. 2024;213:753-762.
    PubMed     Abstract available


    July 2024
  5. SHANAHAN SL, Kunder N, Inaku C, Hagan NB, et al
    Longitudinal Intravascular Antibody Labeling Identified Regulatory T Cell Recruitment as a Therapeutic Target in a Mouse Model of Lung Cancer.
    J Immunol. 2024 Jul 31:ji2400268. doi: 10.4049/jimmunol.2400268.
    PubMed     Abstract available


    May 2024
  6. SAXENA R, Bushey RT, Campa MJ, Gottlin EB, et al
    Promotion of an Antitumor Immune Program by a Tumor-specific, Complement-activating Antibody.
    J Immunol. 2024;212:1589-1601.
    PubMed     Abstract available


    January 2024
  7. TOYOFUKU T, Ishikawa T, Nojima S, Kumanogoh A, et al
    Efficacy against Lung Cancer Is Augmented by Combining Aberrantly N-Glycosylated T Cells with a Chimeric Antigen Receptor Targeting Fragile X Mental Retardation 1 Neighbor.
    J Immunol. 2024 Jan 12:ji2300618. doi: 10.4049/jimmunol.2300618.
    PubMed     Abstract available


    October 2023
  8. RAV E, Maegawa S, Gopalakrishnan V, Gordon N, et al
    Overview of CD70 as a Potential Therapeutic Target for Osteosarcoma.
    J Immunol. 2023;211:1067-1072.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Lung Cancer is free of charge.